loading page

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
  • akiko hashimoto,
  • yasuhiro tanaka,
  • isaku shinzato
akiko hashimoto
Nishi Kobe Medical Center
Author Profile
yasuhiro tanaka
Author Profile
isaku shinzato
Author Profile


A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD

Peer review status:ACCEPTED

26 Dec 2020Submitted to Clinical Case Reports
09 Jan 2021Submission Checks Completed
09 Jan 2021Assigned to Editor
13 Jan 2021Reviewer(s) Assigned
30 Jan 2021Review(s) Completed, Editorial Evaluation Pending
09 Feb 2021Editorial Decision: Revise Minor
08 Mar 20211st Revision Received
14 Apr 2021Submission Checks Completed
14 Apr 2021Assigned to Editor
14 Apr 2021Review(s) Completed, Editorial Evaluation Pending
26 Apr 2021Editorial Decision: Accept